Xcout Intel
Biolojic Design
Biolojic Design is an Israeli biotechnology company that uses computational modeling and artificial intelligence to design and engineer antibodies and other therapeutic proteins. It develops drug candidates and collaborates with pharmaceutical and biotechnology companies seeking novel biologic medicines.
Subscribe to see Biolojic Design’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Biolojic Design at a glance
Biolojic Design is a biotechnology company headquartered in Israel, founded in 2008. Its most recent funding round raised $4M in January 2021. Xcout tracks 1 named person at Biolojic Design, including ROGER WALTZMAN (Chief Medical Officer).
Biolojic Design leadership
- ROGER WALTZMANChief Medical Officer
Biolojic Design funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $4M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Biolojic Design competitors
A few of Biolojic Design's closest competitors — see the full list of competitors and alternatives →
CombinAble.AI is an Israeli biotechnology startup incubated within AION Labs that develops a novel approach to biological drug discovery through the design and optimization of antibodies. The company leverages artificial intelligence to accelerate the development process for biological therapeutics and was acquired by Insitro.
Prellis Biologics, Inc. is a privately held biotechnology company headquartered in Berkeley, California, within the San Francisco Bay Area. It develops human antibody therapeutics and focuses on antibody discovery leveraging AI and immune diversity.
9Bio Therapeutics is a biotechnology company that combines biology, structural engineering, and artificial intelligence to pioneer next-generation biologics for advanced cancers. The company is headquartered in Quebec, Canada.
immunitoAI is a TechBio research company founded in 2020 that develops AI-driven platforms to unlock the potential of antibody therapeutics. Headquartered in Bengaluru, Karnataka, India, the company employs a team of 11 to 50 professionals.
Metaphore Biotechnologies, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, operating as part of Flagship Pioneering. The company focuses on therapeutic design, leveraging AI and machine learning technologies for drug discovery and development.
Get Biolojic Design's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Biolojic Design in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access